Cargando…

Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System

BACKGROUND AND AIMS: Intrahepatic cholangiocarcinoma (iCCA) with liver metastases is perceived to have a poor prognosis, but the American Joint Committee on Cancer (AJCC) classifies them as early stage in the absence of lymph nodes or extrahepatic spread. APPROACH AND RESULTS: Patients with iCCA fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamarca, Angela, Santos‐Laso, Alvaro, Utpatel, Kirsten, La Casta, Adelaida, Stock, Simone, Forner, Alejandro, Adeva, Jorge, Folseraas, Trine, Fabris, Luca, Macias, Rocio I.R., Krawczyk, Marcin, Krawczyk, Marek, Cardinale, Vincenzo, Braconi, Chiara, Alvaro, Domenico, Evert, Matthias, Banales, Jesus M., Valle, Juan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252018/
https://www.ncbi.nlm.nih.gov/pubmed/33073396
http://dx.doi.org/10.1002/hep.31598
_version_ 1783717213786603520
author Lamarca, Angela
Santos‐Laso, Alvaro
Utpatel, Kirsten
La Casta, Adelaida
Stock, Simone
Forner, Alejandro
Adeva, Jorge
Folseraas, Trine
Fabris, Luca
Macias, Rocio I.R.
Krawczyk, Marcin
Krawczyk, Marek
Cardinale, Vincenzo
Braconi, Chiara
Alvaro, Domenico
Evert, Matthias
Banales, Jesus M.
Valle, Juan W.
author_facet Lamarca, Angela
Santos‐Laso, Alvaro
Utpatel, Kirsten
La Casta, Adelaida
Stock, Simone
Forner, Alejandro
Adeva, Jorge
Folseraas, Trine
Fabris, Luca
Macias, Rocio I.R.
Krawczyk, Marcin
Krawczyk, Marek
Cardinale, Vincenzo
Braconi, Chiara
Alvaro, Domenico
Evert, Matthias
Banales, Jesus M.
Valle, Juan W.
author_sort Lamarca, Angela
collection PubMed
description BACKGROUND AND AIMS: Intrahepatic cholangiocarcinoma (iCCA) with liver metastases is perceived to have a poor prognosis, but the American Joint Committee on Cancer (AJCC) classifies them as early stage in the absence of lymph nodes or extrahepatic spread. APPROACH AND RESULTS: Patients with iCCA from the European Network for the Study of Cholangiocarcinoma (ENS‐CCA) and Surveillance, Epidemiology, and End Results (SEER) registries with survival/staging (AJCC v.7) data were eligible. Modified staging was used (mAJCC v.7): group A: stages I‐III (excluding T2bN0); group B: stage IVa (excluding T2bN1M0); group C: liver metastases (T2bN0/1); and group D: stage IVb (extrahepatic metastases). Survival analysis (Kaplan‐Meier and Cox regression) was performed in an ENS‐CCA training cohort (TC) and findings internally (ENS‐CCA iVC) and externally (SEER) validated. The aim was to assess whether liver metastases (group C) had a shorter survival compared to other early stages (group A) to propose a modified version of AJCC v.8 (mAJCC v.8). A total of 574 and 4,171 patients from the ENS‐CCA and SEER registries were included. Following the new classification, 19.86% and 17.31% of patients from the ENS‐CCA and SEER registries were reclassified into group C, respectively. In the ENS‐CCA TC, multivariable Cox regression was adjusted for obesity (p = 0.026) and performance status (P < 0.001); patients in group C (HR, 2.53; 95% CI, 1.18‐5.42; P = 0.017) had a higher risk of death (vs. group A). Findings were validated in the ENS‐CCA iVC (HR, 2.93; 95% CI, 2.04‐4.19; P < 0.001) and in the SEER registry (HR, 1.88; 95% CI, 1.68‐2.09; P < 0.001). CONCLUSIONS: iCCA with liver metastases has a worse outcome than other early stages of iCCA. Given that AJCC v.8 does not take this into consideration, a modification of AJCC v.8 (mAJCC v.8), including “liver metastases: multiple liver lesions, with or without vascular invasion” as an “M1a stage,” is suggested.
format Online
Article
Text
id pubmed-8252018
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82520182021-07-07 Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System Lamarca, Angela Santos‐Laso, Alvaro Utpatel, Kirsten La Casta, Adelaida Stock, Simone Forner, Alejandro Adeva, Jorge Folseraas, Trine Fabris, Luca Macias, Rocio I.R. Krawczyk, Marcin Krawczyk, Marek Cardinale, Vincenzo Braconi, Chiara Alvaro, Domenico Evert, Matthias Banales, Jesus M. Valle, Juan W. Hepatology Original Articles BACKGROUND AND AIMS: Intrahepatic cholangiocarcinoma (iCCA) with liver metastases is perceived to have a poor prognosis, but the American Joint Committee on Cancer (AJCC) classifies them as early stage in the absence of lymph nodes or extrahepatic spread. APPROACH AND RESULTS: Patients with iCCA from the European Network for the Study of Cholangiocarcinoma (ENS‐CCA) and Surveillance, Epidemiology, and End Results (SEER) registries with survival/staging (AJCC v.7) data were eligible. Modified staging was used (mAJCC v.7): group A: stages I‐III (excluding T2bN0); group B: stage IVa (excluding T2bN1M0); group C: liver metastases (T2bN0/1); and group D: stage IVb (extrahepatic metastases). Survival analysis (Kaplan‐Meier and Cox regression) was performed in an ENS‐CCA training cohort (TC) and findings internally (ENS‐CCA iVC) and externally (SEER) validated. The aim was to assess whether liver metastases (group C) had a shorter survival compared to other early stages (group A) to propose a modified version of AJCC v.8 (mAJCC v.8). A total of 574 and 4,171 patients from the ENS‐CCA and SEER registries were included. Following the new classification, 19.86% and 17.31% of patients from the ENS‐CCA and SEER registries were reclassified into group C, respectively. In the ENS‐CCA TC, multivariable Cox regression was adjusted for obesity (p = 0.026) and performance status (P < 0.001); patients in group C (HR, 2.53; 95% CI, 1.18‐5.42; P = 0.017) had a higher risk of death (vs. group A). Findings were validated in the ENS‐CCA iVC (HR, 2.93; 95% CI, 2.04‐4.19; P < 0.001) and in the SEER registry (HR, 1.88; 95% CI, 1.68‐2.09; P < 0.001). CONCLUSIONS: iCCA with liver metastases has a worse outcome than other early stages of iCCA. Given that AJCC v.8 does not take this into consideration, a modification of AJCC v.8 (mAJCC v.8), including “liver metastases: multiple liver lesions, with or without vascular invasion” as an “M1a stage,” is suggested. John Wiley and Sons Inc. 2021-06-18 2021-06 /pmc/articles/PMC8252018/ /pubmed/33073396 http://dx.doi.org/10.1002/hep.31598 Text en © 2020 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Lamarca, Angela
Santos‐Laso, Alvaro
Utpatel, Kirsten
La Casta, Adelaida
Stock, Simone
Forner, Alejandro
Adeva, Jorge
Folseraas, Trine
Fabris, Luca
Macias, Rocio I.R.
Krawczyk, Marcin
Krawczyk, Marek
Cardinale, Vincenzo
Braconi, Chiara
Alvaro, Domenico
Evert, Matthias
Banales, Jesus M.
Valle, Juan W.
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
title Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
title_full Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
title_fullStr Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
title_full_unstemmed Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
title_short Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
title_sort liver metastases of intrahepatic cholangiocarcinoma: implications for an updated staging system
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252018/
https://www.ncbi.nlm.nih.gov/pubmed/33073396
http://dx.doi.org/10.1002/hep.31598
work_keys_str_mv AT lamarcaangela livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT santoslasoalvaro livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT utpatelkirsten livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT lacastaadelaida livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT stocksimone livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT forneralejandro livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT adevajorge livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT folseraastrine livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT fabrisluca livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT maciasrocioir livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT krawczykmarcin livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT krawczykmarek livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT cardinalevincenzo livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT braconichiara livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT alvarodomenico livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT evertmatthias livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT banalesjesusm livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT vallejuanw livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem
AT livermetastasesofintrahepaticcholangiocarcinomaimplicationsforanupdatedstagingsystem